Juan Pablo Kaski

8.1k total citations
100 papers, 1.6k citations indexed

About

Juan Pablo Kaski is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Juan Pablo Kaski has authored 100 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Cardiology and Cardiovascular Medicine, 34 papers in Epidemiology and 22 papers in Molecular Biology. Recurrent topics in Juan Pablo Kaski's work include Cardiomyopathy and Myosin Studies (65 papers), Cardiovascular Effects of Exercise (28 papers) and Congenital Heart Disease Studies (26 papers). Juan Pablo Kaski is often cited by papers focused on Cardiomyopathy and Myosin Studies (65 papers), Cardiovascular Effects of Exercise (28 papers) and Congenital Heart Disease Studies (26 papers). Juan Pablo Kaski collaborates with scholars based in United Kingdom, Italy and United States. Juan Pablo Kaski's co-authors include Perry Elliott, Petros Syrris, William J. McKenna, Gabrielle Norrish, Maite Tome, John Deanfield, Ella Field, Jeffrey P. Moak, Giuseppe Limongelli and Sharon Jenkins and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Juan Pablo Kaski

90 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Juan Pablo Kaski United Kingdom	21	1.3k	508	315	154	65	100	1.6k
Amanda Varnava United Kingdom	14	2.1k 1.6×	265 0.5×	251 0.8×	416 2.7×	71 1.1×	35	2.6k
Roberto Barriales‐Villa Spain	21	923 0.7×	360 0.7×	203 0.6×	202 1.3×	6 0.1×	116	1.3k
Luís R. Lopes United Kingdom	26	1.6k 1.3×	606 1.2×	251 0.8×	163 1.1×	16 0.2×	134	1.9k
Kalliopi Pilichou Italy	27	2.9k 2.3×	371 0.7×	226 0.7×	416 2.7×	161 2.5×	82	3.2k
Johannes Holzmeister Switzerland	21	1.4k 1.1×	153 0.3×	113 0.4×	221 1.4×	41 0.6×	47	1.7k
Deborah U. Frank United States	18	297 0.2×	844 1.7×	462 1.5×	411 2.7×	107 1.6×	38	1.6k
E Villain France	19	1.5k 1.2×	534 1.1×	247 0.8×	218 1.4×	32 0.5×	55	1.9k
Giovanni Quarta United Kingdom	18	1.7k 1.4×	170 0.3×	126 0.4×	223 1.4×	73 1.1×	27	2.2k
Nupoor Narula United States	14	522 0.4×	225 0.4×	47 0.1×	154 1.0×	13 0.2×	34	850
Mohsin A.F. Khan United Kingdom	16	470 0.4×	641 1.3×	52 0.2×	72 0.5×	7 0.1×	23	1.1k

Countries citing papers authored by Juan Pablo Kaski

Since Specialization

Citations

This map shows the geographic impact of Juan Pablo Kaski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Pablo Kaski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Pablo Kaski more than expected).

Fields of papers citing papers by Juan Pablo Kaski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Pablo Kaski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Pablo Kaski. The network helps show where Juan Pablo Kaski may publish in the future.

Co-authorship network of co-authors of Juan Pablo Kaski

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Pablo Kaski. A scholar is included among the top collaborators of Juan Pablo Kaski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Pablo Kaski. Juan Pablo Kaski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mizia‐Stec, Katarzyna, Juan R. Gimeno, Philippe Charron, et al.. (2025). Hypertrophic cardiomyopathy and atrial fibrillation: the Cardiomyopathy/Myocarditis Registry of the EURObservational Research Programme of the European Society of Cardiology. Open Heart. 12(1). e002876–e002876. 1 indexed citations

Kaski, Juan Pablo, Paul F. Kantor, Stephanie J. Nakano, et al.. (2025). Efficacy and Safety of Aficamten in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy: Study Design and Rationale of CEDAR-HCM. Circulation Heart Failure. 19(2). e013418–e013418.

Palma, Cárol, et al.. (2025). Imaging based risk factors for heart failure death in childhood dilated cardiomyopathy: a systematic review and meta-analysis. Frontiers in Cardiovascular Medicine. 12. 1568494–1568494. 1 indexed citations

Schunkert, Heribert, Emanuele Di Angelantonio, Michael Inouye, et al.. (2024). Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease. European Heart Journal. 46(15). 1372–1383. 25 indexed citations

Monda, Emanuele, Athanasios Bakalakos, Douglas Cannie, et al.. (2024). Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Acute Myocarditis. JACC Heart Failure. 12(6). 1101–1111. 22 indexed citations

Captur, Gabriella, Ivan Doykov, Sheng‐Chia Chung, et al.. (2024). Novel Multiplexed Plasma Biomarker Panel Has Diagnostic and Prognostic Potential in Children With Hypertrophic Cardiomyopathy. Circulation Genomic and Precision Medicine. 17(3). e004448–e004448. 4 indexed citations

Monda, Emanuele, Athanasios Bakalakos, Douglas Cannie, et al.. (2024). Prevalence of pathogenic variants in cardiomyopathy-associated genes in acute myocarditis: a systematic review and meta-analysis. European Heart Journal. 45(Supplement_1). 1 indexed citations

Norrish, Gabrielle, et al.. (2024). Childhood-onset hypertrophic cardiomyopathy caused by thin-filament sarcomeric variants. Journal of Medical Genetics. 61(5). 420–422. 2 indexed citations

Hong, Kimberly N., et al.. (2024). Challenges in Cardiomyopathy Gene Therapy Clinical Trial Design. JACC Heart Failure. 13(1). 154–166. 2 indexed citations

10.

Bueno‐Betí, Carlos, Stephen P. Chelko, Mary N. Sheppard, et al.. (2023). Innate immune signaling in hearts and buccal mucosa cells of patients with arrhythmogenic cardiomyopathy. Heart Rhythm O2. 4(10). 650–659. 6 indexed citations

11.

Norrish, Gabrielle, Ella Field, Karen McLeod, et al.. (2023). Childhood Hypertrophic Cardiomyopathy Caused by Beta-Myosin Heavy Chain Variants Is Associated With a More Obstructive but Less Arrhythmogenic Phenotype Than Myosin-Binding Protein C Disease. Circulation Genomic and Precision Medicine. 16(5). 483–485. 1 indexed citations

12.

Kaski, Juan Pablo, Janneke A.E. Kammeraad, Nico A. Blom, et al.. (2023). Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy. Cardiology in the Young. 33(5). 681–698. 8 indexed citations

13.

Protonotarios, Alexandros, et al.. (2023). Performance of the PRIMaCY sudden death risk prediction model for childhood hypertrophic cardiomyopathy: implications for implantable cardioverter-defibrillator decision-making. EP Europace. 25(11). 4 indexed citations

14.

Monda, Emanuele, Michele Lioncino, Gabrielle Norrish, et al.. (2023). Natural History of Hypertrophic Cardiomyopathy in Noonan Syndrome With Multiple Lentigines. Circulation Genomic and Precision Medicine. 16(4). 350–358. 9 indexed citations

15.

Norrish, Gabrielle, Elena Montañés, Ella Field, et al.. (2021). Friedreich’s ataxia-associated childhood hypertrophic cardiomyopathy: a national cohort study. Archives of Disease in Childhood. 107(5). 450–455. 14 indexed citations

16.

Gimeno, Juan R., Perry Elliott, Luigi Tavazzi, et al.. (2020). Prospective follow-up in various subtypes of cardiomyopathies: insights from the ESC EORP Cardiomyopathy Registry. European Heart Journal - Quality of Care and Clinical Outcomes. 7(2). 134–142. 5 indexed citations

17.

Mizia‐Stec, Katarzyna, Alida L.P. Caforio, Philippe Charron, et al.. (2020). Atrial Fibrillation, Anticoagulation Management and Risk of Stroke in the Cardiomyopathy/Myocarditis Registry of the EURObservational Research Programme of the European Society of Cardiology. ESC Heart Failure. 7(6). 3601–3609. 15 indexed citations

18.

Norrish, Gabrielle, Tao Ding, Ella Field, et al.. (2019). 227A novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM Risk-Kids). European Heart Journal. 40(Supplement_1). 9 indexed citations

19.

Norrish, Gabrielle, et al.. (2016). High prevalence of early repolarization in the paediatric relatives of sudden arrhythmic death syndrome victims and in normal controls. EP Europace. 19(8). 1385–1391. 7 indexed citations

20.

Kaski, Juan Pablo, Maite Tome, Antonios Pantazis, et al.. (2007). B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy. Heart. 94(10). 1307–1311. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact